Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-26

Clinical Trial Update: Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating bupivacaine versus placebo for postoperative pain control after unilateral mastectomy in breast cancer patients. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING